Mangoceuticals, Inc. (NASDAQ:MGRX) Short Interest Update

Mangoceuticals, Inc. (NASDAQ:MGRX) saw a significant decrease in short interest in the month of December. As of December 31st, there was short interest totalling 42,200 shares, a decrease of 23.1% from the December 15th total of 54,900 shares. Based on an average trading volume of 167,600 shares, the short-interest ratio is presently 0.3 days. Currently, 2.4% of the company’s shares are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Mangoceuticals stock. Ackerman Capital Advisors LLC purchased a new position in shares of Mangoceuticals, Inc. (NASDAQ:MGRX) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 873,356 shares of the company’s stock, valued at approximately $206,000. Ackerman Capital Advisors LLC owned 3.52% of Mangoceuticals as of its most recent SEC filing. Hedge funds and other institutional investors own 56.72% of the company’s stock.

Mangoceuticals Trading Down 2.6 %

Mangoceuticals stock traded down $0.07 during mid-day trading on Friday, hitting $2.61. The company’s stock had a trading volume of 38,847 shares, compared to its average volume of 44,268. The firm has a market capitalization of $6.50 million, a PE ratio of -0.45 and a beta of 1.94. Mangoceuticals has a 1 year low of $2.07 and a 1 year high of $16.80. The stock’s fifty day moving average is $2.52 and its two-hundred day moving average is $37.32.

Mangoceuticals Company Profile

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.